논문 상세보기

Maintenance of stem cell characteristics after long-term cryopreservation

  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/354635
서비스가 종료되어 열람이 제한될 수 있습니다.
한국발생생물학회 (The Korea Society Of Developmental Biology)
초록

The human eyelid adipose-derived stem cells (HEACs) are known as a candidate source for stem cell-based therapy. HEACs possess the ability to proliferate in vitro and multipotency to differentiate into adipogenic, osteogenic and chondrogenic cells. To be used later than the time of collection, a long-term storage is needed. In this study, we investigated stem cell characteristics after cryopreservation of HEACs for 6 months and 1 year in liquid nitrogen. Frozen-thawed stem cells have shown that cumulative cell and doubling numbers were similar to those of fresh HEACs. After thawing, HEACs expressed stem cell-related genes of SCF, NANOG, OCT4, and TERT, ectoderm-related genes of NCAM and FGF5, mesoderm/endoderm-related genes of CK18 and VIM. They also consistently expressed transcripts of the immune-related genes of HLA-ABC and β2M. To induce mesodermal differentiation, cell were cultivated in adipogenic, osteogenic or chondrogenic medium for 2~3 weeks. After each differentiation culture, HEACs expressed adipocyte-, osteocyte- and chondrocytespecific genes. They were also stained with Oil red O, von Kossa, or alcian blue, revealing adipogenic, osteogenic, or chondrogenic character, respectively. The results suggest that long-term storage up to 1 year do not affect their biological properties, HEACs may be suitable for clinical application on cell-based therapies.

저자
  • Yeonhwa Song(Department of Biotechnology, Seoul Women's University)
  • Sujin Yun(Department of Biotechnology, Seoul Women's University)
  • Jiyoung Kim(Bcellbio Inc.)
  • Hyun Mi Kang(Bcellbio Inc.)
  • Seah Park(Department of Biotechnology, Seoul Women's University, Bcellbio Inc.)
  • Hye Jin Yang(Department of Biotechnology, Seoul Women's University)
  • A young Yoon(Department of Biotechnology, Seoul Women's University)
  • Sun Young Baek(Korea Food & Drug Administration)
  • Si Hyung Yoo(Korea Food & Drug Administration)
  • Sun Hee Kim(Korea Food & Drug Administration)
  • Haekwon Kim(Department of Biotechnology, Seoul Women's University, Bcellbio Inc.)